Almanack Investment Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$310K Buy
337
+24
+8% +$24.3K 0.05% 128
2025
Q4
$336K Sell
313
-279
-47% -$267K 0.06% 124
2025
Q3
$451K Sell
592
-147
-20% -$109K 0.07% 122
2025
Q2
$576K Sell
739
-280
-27% -$218K 0.09% 111
2025
Q1
$842K Buy
1,019
+355
+53% +$295K 0.17% 68
2024
Q4
$513K Sell
664
-308
-32% -$255K 0.08% 109
2024
Q3
$861K Buy
972
+6
+0.6% +$5.39K 0.14% 84
2024
Q2
$875K Buy
+966
New +$773K 0.15% 81
2024
Q1
Sell
-891
Closed -$752K 180
2023
Q4
$752K Sell
891
-1,544
-63% -$901K 0.14% 75
2023
Q3
$1.31M Buy
2,435
+1,031
+73% +$531K 0.25% 47
2023
Q2
$659K Buy
1,404
+302
+27% +$127K 0.12% 77
2023
Q1
$378K Sell
1,102
-415
-27% -$140K 0.07% 108
2022
Q4
$555K Sell
1,517
-1,092
-42% -$387K 0.12% 77
2022
Q3
$844K Buy
2,609
+991
+61% +$314K 0.17% 59
2022
Q2
$525K Buy
1,618
+376
+30% +$113K 0.05% 224
2022
Q1
$356K Buy
1,242
+315
+34% +$81.1K 0.03% 319
2021
Q4
$256K Buy
+927
New +$235K 0.02% 410
2020
Q4
Sell
-3,602
Closed -$528K 434
2020
Q3
$528K Buy
3,602
+190
+6% +$29.4K 0.07% 198
2020
Q2
$560K Buy
+3,412
New +$524K 0.1% 115

Other funds holding LLY

Almanack Investment Partners's LLY Position: Q1 2026 in Review

Almanack Investment Partners increased its Eli Lilly (LLY) stake by 7.7% in Q1 2026, buying an estimated $24.3K and bringing the position to 337 shares worth $310K. The position accounts for 0.05% of the portfolio, ranked #128.

Almanack Investment Partners first reported a position in LLY in Q2 2020 and has held it in 19 quarters since. The position peaked at $1.31M in Q3 2023. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Almanack Investment Partners held 337 shares of Eli Lilly worth $310K as of Q1 2026.
  • Almanack Investment Partners bought 24 Eli Lilly shares in Q1 2026, an estimated $24.3K.
  • Eli Lilly made up 0.05% of Almanack Investment Partners's portfolio in Q1 2026, its #128 holding.
  • Almanack Investment Partners first reported a position in Eli Lilly in Q2 2020 and has held it in 19 quarters since.
  • Almanack Investment Partners's Eli Lilly position peaked at $1.31M in Q3 2023.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Almanack Investment Partners's 13F filing for Q1 2026, filed 5 May 2026.